Facebook Users

Will EBOI go up?

EBOI Enhance Biotech Inc. featured news, full reports, and detailed charts

Enhance Biotech Inc. (EBOI/EBOI.PK) Wrap Up:

Enhance Biotech, Inc., a development stage company, engages in the acquisition, development, and commercialization of therapeutic drugs. Its product pipeline includes 13 products under development in three main groups: Urology, Dermatology, and Central Nervous System disorders. The company’s Urology products include LI-301 for the delay of ejaculation in men and DPI-221 for urinary incontinence. Its Dermatology products include LI-303 for cellulite, LI-312 for psoriasis and atopic dermatitis, LI-412 for eczema/itch, and LI-236 for anti-aging. The company is also developing drugs for treating Central Nervous System disorders, including cDPI-125 for moderate to severe pain, DPI-289 for depress...
www.enhancebiotech.com
15 Employees

Enhance Biotech Inc. (EBOI:OTC)

Market Cap
61.2K
Total Revenue
--
EBITDA
9.8M
DILUTED EPS TTM
-1.34
P/E
--
P/S
--
Return On Asset
--
Return On Equity
--
K = Thousands  M = Millions  B = Billions

EBOI Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

otc, otcbb, pinksheet, EBOI, ob Enhance Biotech Inc.

EBOI Competitors

Company Last Change
No competitor information is available for EBOI.
Market data is delayed at least 20 minutes.

Industry Analysis

Valuation EBOI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

EBOI

EBOI transactions

Type
Date
Target
No transactions in the last 6 months.

More Recent News About Enhance Biotech Inc.

Would you like to leave a comment about Enhance Biotech Inc. EBOI/EBOI.PK

Besides Enhance Biotech Inc. there is more great information available at Realpennies.com